Who are the young bio­phar­ma lead­ers shap­ing the in­dus­try in 2022? Nom­i­nate them for End­points' spe­cial re­port

Up­date: Nom­i­na­tions are now closed

Drug de­vel­op­ment can some­times seem like a mid­dle-aged game, but of­ten­times the in­spi­ra­tion for the in­dus­try’s biggest in­no­va­tions came when its cre­ators were far younger.

Take CAR-T, the cell ther­a­py re­searchers de­clared this month could con­clu­sive­ly cure some pa­tients. Even though Carl June was push­ing 60 when the ther­a­py showed its first dra­mat­ic re­sults a decade ago, he start­ed work­ing on the field as a young Navy doc in the 1980s.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER